Untitled 1

Bad blood : (Record no. 47547)

MARC details
000 -LEADER
fixed length control field 03116cam a2200361 i 4500
001 - CONTROL NUMBER
control field on1091999679
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220822144248.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180316t20192018enk e b 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781509868087
Qualifying information (paperback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1509868089
Qualifying information (paperback)
029 0# - (OCLC)
OCLC library identifier AU@
System control number 000065146890
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000065199025
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1091999679
Canceled/invalid control number (OCoLC)1111084400
040 ## - CATALOGING SOURCE
Original cataloging agency AU@
Language of cataloging eng
Description conventions rda
Transcribing agency AU@
Modifying agency OCLCO
-- OCLCF
-- U3W
-- OCLCQ
-- OCL
-- OMB
-- AUPTL
-- OCLCQ
-- OCLCO
043 ## - GEOGRAPHIC AREA CODE
Geographic area code n-us---
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number HD9995.H424
Item number T44 2019
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.7
Edition number 23
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Carreyrou, John,
Relator term author.
9 (RLIN) 51545
245 10 - TITLE STATEMENT
Title Bad blood :
Remainder of title secrets and lies in a Silicon Valley startup /
Statement of responsibility, etc John Carreyrou.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc London
Name of publisher, distributor, etc Picador, an imprint of Pan Macmillan
Date of publication, distribution, etc [2018]
300 ## - PHYSICAL DESCRIPTION
Extent x, 339 pages ;
Dimensions 20 cm
500 ## - GENERAL NOTE
General note Originally published: 2018.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references (pages 305-324) and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La Mattanza -- Damage control -- The empress has no clothes -- Epilogue -- Afterword.
520 ## - SUMMARY, ETC.
Summary, etc The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley
610 #0 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Theranos (Firm)
General subdivision History.
9 (RLIN) 51546
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Hematologic equipment industry
Geographic subdivision United States.
9 (RLIN) 51547
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Fraud
Geographic subdivision United States.
9 (RLIN) 51548
651 #7 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Geographic name United States.
Source of heading or term fast
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Non-Fiction
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN)
h (OCLC) NO HOLDINGS IN NZWMT - 84 OTHER HOLDINGS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Total Renewals Full call number Barcode Date last seen Date checked out Price effective from Koha item type Public note
    Dewey Decimal Classification   Not For Loan Non Fiction Waimate Waimate Located at Event Centre 22/08/2022 WHE 20.00 1 338.7 A00802852 30/10/2023 03/10/2023 22/08/2022 Non-Fiction Not For Loan
Waimate District Council
Home | Contact Us
(c) 2015 Waimate District Library. Powered by Koha.